Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrad Adibi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Urologic Oncology|February 22, 2024
Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancerManuel Ozambela, Barrett Z McCormick, Jan K Rudzinski, et al.
BJU International|October 26, 2022
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort studyKyle M Rose, Gopal Narang, Geoffrey Rosen, et al.
Urologic Oncology|May 26, 2015
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiationMehrad Adibi, Arun Z Thomas, Leonardo D Borregales, et al.
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
BJUI Compass|April 27, 2022
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinomaOmar Alhalabi, Matthew T Campbell, Lianchun Xiao, et al.
European Urology Focus|November 6, 2019
Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial NephrectomyLeonardo D Borregales, Mehrad Adibi, Arun Z Thomas, et al.
Urologic Oncology|August 12, 2022
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinomaCraig V Labbate, Patrick J Hensley, Tanner S Miest, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
European Urology|March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate CancerBrian F Chapin, Marc Smaldone, Amado J Zurita, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Urologic Oncology|February 22, 2024
Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancerManuel Ozambela, Barrett Z McCormick, Jan K Rudzinski, et al.
BJU International|October 26, 2022
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort studyKyle M Rose, Gopal Narang, Geoffrey Rosen, et al.
Urologic Oncology|May 26, 2015
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiationMehrad Adibi, Arun Z Thomas, Leonardo D Borregales, et al.
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
BJUI Compass|April 27, 2022
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinomaOmar Alhalabi, Matthew T Campbell, Lianchun Xiao, et al.
European Urology Focus|November 6, 2019
Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial NephrectomyLeonardo D Borregales, Mehrad Adibi, Arun Z Thomas, et al.
Urologic Oncology|August 12, 2022
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinomaCraig V Labbate, Patrick J Hensley, Tanner S Miest, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
European Urology|March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate CancerBrian F Chapin, Marc Smaldone, Amado J Zurita, et al.
Pageof 4